
Francesca Petralia, PhD
About Me
Dr. Petralia received a PhD in Statistics from Duke University in 2013. She then joined the Department of Genetics and Genomic Sciences where she develops statistical and computational methods to address scientific questions based on data from high throughput biology/genetics experiments. Specifically, she works on the integration of proteogenomics data, the quantification of different cell types in cancer tissue from genomics data and network analysis.
Petralia Lab website at https://labs.icahn.mssm.edu/petralialab/
Language
English
Position
ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Publications
Selected Publications
- Proteogenomic analysis of pediatric and AYA high-grade glioma reveals age-dependent biology, female-male differences, and kinase targets. Nicole L. Tignor, Mateusz Koptyra, Shrabanti Chowdhury, Francesca Petralia, Marina A. Gritsenko, Weiping Ma, Yuankun Zhu, Giacomo B. Marino, Xiaoyu Song, Simona Migliozzi, Jeffrey R. Whiteaker, Dmitry Rykunov, Yingwei Hu, Noshad Hosseini, Jo Lynne Rokita, Felipe da Veiga Leprevost, Komal S. Rathi, Lijun Chen, Yi Ting Wang, Karl K. Weitz, Rosalie K. Chu, Ronald J. Moore, Azra Krek, Weijia Fu, Xuran Wang, Eden Z. Deng, Chia Feng Tsai, Tyler Sagendorf, Vladislav A. Petyuk, Tujin Shi, Thomas L. Fillmore, Rui Zhao, Matthew E. Monroe, Marius V. Dannappel, Paul Daniel, Lei Zhao, Richard G. Ivey, Uliana J. Voytovich, Tomer M. Yaron-Barir, Emily M. Huntsman, Jared L. Johnson, Nakib Abedin, Yan Chak Li, Mariarita Santi, Demetri Dupal, Jena Lilly, Boris Reva, Eric E. Schadt, Avi Ma'ayan, Pei Wang. Cell reports. Medicine
- Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets. Shih Chun A. Chu, Yi Hsiao, Chenwei Wang, Jennifer E. Kyle, Raghav Jain, Yamei Deng, Marina A. Gritsenko, Leanne E. Henry, Jonathan T. Lei, Yongchao Dou, Bahar Tercan, Zhiao Shi, Mahnoor N. Gondal, Chia Feng Tsai, John M. Elizarraras, Rosalie K. Chu, Fengchao Yu, Sunil K. Joshi, Xiaojun Jing, Daniel A. Polasky, Karl K. Weitz, Ginny Xiaohe Li, Vanessa L. Paurus, Chaevien S. Clendinen, Athena A. Schepmoes, Priscila M. Lalli, Josie G. Eder, Javier E. Flores, Kelly G. Stratton, James C. Pino, Camilo Posso, Vladislav A. Petyuk, Tyler J. Sagendorf, Yuanwei Xu, Omar M. Ibrahim, Ronald J. Moore, Rui Zhao, Jin Chen, Matthew E. Monroe, Mathangi Thiagarajan, Galen Hostetter, Chelsea Newton, Eunkyung An, Ana I. Robles, Xu Zhang, Nathan J. Edwards, Yin Lu, Pei Wang, Francesca Petralia, Avi Ma’ayan. Nature Cancer
- Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trial. Laurie Keefer, Ryan Ungaro, Ayanna Lewis, Josie Lee, Candela de Amorrortu, Taryn Lores, Tina Siganporia, Saurabh Mehandru, Francesca Petralia, Jean Frederic Colombel. Contemporary Clinical Trials
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Petralia has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.